Running summarizing tools on a new article

Check the paper below, then start its synthesis.


Therapeutics and Clinical Risk Management

Therapeutics and Clinical Risk Management
License: not stated (all rights reserved)

Abstract: Indexed:EmBase, Scopus and the Elsevier Bibliographic databases American Chemical Society's Chemical Abstracts Service (CAS)PubMedISSN 1176-6336 (Print)ISSN 1178-203X (Online)An international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines.Key benefitsConcise rapid reportingClinical studiesSafetyAims and scopeThe journal will explore the evidence and opinion behind new and existing therapies and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.Subject areas include:Clinical studies throughout the drug development process (clinical trials, pharmacodynamic, kinetic reports), including individual compounds, combinations, and new formulationsSafety and post-marketing surveillance studiesOutcomes studies and economic analyses of drug treatment and disease, including modelingDrug management of specific diseases, clinical guidelines, formulary management, and drug utilization reviewsRisk management programsPatient and health education programs and studiesCompliance, concordance, and persistency studiesHealth literacy studies and surveysThese areas are addressed through:Original research (full papers and concise rapid reports)ReviewsSystematic reviews of individual new or important drugs where a change in therapeutic management of a disease may be indicatedExpert opinion and commentary

Published on 03 Mar. 2020